Open innovation

Promoting R&D Activities through Open Innovation

Sysmex RDCE embraces open innovation – integration of internal and external knowledge, ideas and technologies - which enables it to accelerate efficient new clinical value generation. Our R&D activities are aimed at creation of “new applications for existing platforms” and “new elemental technologies” based on open innovation. Especially regarding application development, our ambition is to realize seeds awaiting to be put into practical use on our platforms. RDCE laboratories are well equipped with principal analytical instruments for our state-of-the-art platforms so that efficient and effective collaborative R&D activities could be realized.

RDCE laboratories

Our laboratories have capabilities for any evaluations and investigations regarding cell, protein and genes analysis with principal analytical instruments and our state-of-the-art platforms.

Cell lab

The cell lab is equipped with both conventional flow cytometry (FCM) and our state-of-the-art molecular imaging FCM platforms. We are working on technologies to allow the specific detection of nucleic acids, organelles, and other elements within cells, as well as the detection of in-cell protein locations and chromosomal aberrations.

Principal instruments:

  • Molecular Imaging Flow Cytometer
  • Automated Hematology Analyzer
  • Conventional flow cytometry

Protein lab

The protein lab is equipped with from ELISA testing system to our ultrasensitive immunoassay platform. We are working on technologies to detect proteins in blood and urine at high speeds and with a high degree of precision, and further enhancing testing parameters. Our lab is also equipped with a brand-new exosome counter* developed by JVC kenwood. (*Sysmex group is jointly developing a diagnostic device for exosomes with JVC Kenwood.)

Principal instruments:

  • Ultrasensitive Immunoassay System
  • Automated Immunoassay System
  • Digital Exosome counting system*
  • HPLC system
  • ELISA testing system

Gene lab

The gene lab is equipped with from conventional PCR system to next generation sequencer. We are working on technologies to enable gene quantification of  cancer cells and the detection of circulating cancer cell-derived DNA.

Principal instruments:

  • Next-generation Sequencer
  • Thermal cycler


We are welcoming collaborators to enhance technologies contributing to healthcare advancement.

Copyright © Sysmex Europe GmbH. All rights reserved.
Customize your experience

We use cookies to enable you to optimally use our Website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

* May lead to restrictions in content and in the user experience
Detail about cookies
Essential cookies
These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.
Statistics cookies
By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.
Marketing cookies
are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.